Skip to main content

Advertisement

Log in

Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma

  • Pancreas
  • Published:
Abdominal Radiology Aims and scope Submit manuscript

Abstract

Purpose

To develop and validate an automated magnetic resonance imaging (MRI)-based model to preoperatively differentiate pancreatic adenosquamous carcinoma (PASC) from pancreatic ductal adenocarcinoma (PDAC).

Methods

This retrospective study included patients with surgically resected, histopathologically confirmed PASC or PDAC who underwent MRI between January 2011 and December 2020. According to time of treatment, they were divided into training and validation sets. Automated deep-learning-based artificial intelligence was used for pancreatic tumor segmentation. Linear discriminant analysis was performed with conventional MRI and radiomic features to develop clinical, radiomics, and mixed models in the training set. The models’ performances were determined from their discrimination and clinical utility. Kaplan–Meier and log-rank tests were used for survival analysis.

Results

Overall, 389 and 123 patients with PDAC (age, 61.37 ± 9.47 years; 251 men) and PASC (age, 61.99 ± 9.82 years; 78 men) were included, respectively; they were split into the training (n = 358) and validation (n = 154) sets. The mixed model showed good performance in the training and validation sets (area under the curve: 0.94 and 0.96, respectively). The sensitivity, specificity, and accuracy were 76.74%, 93.38%, and 89.39% for the training set, respectively, and 67.57%, 97.44%, and 90.26% for the validation set, respectively. The mixed model outperformed the clinical (p = 0.001) and radiomics (p = 0.04) models in the validation set. Log-rank test revealed significantly longer survival in the predicted PDAC group than in the predicted PASC group (p = 0.003), according to the mixed model.

Conclusion

Our mixed model, which combined MRI and radiomic features, can be used to differentiate PASC from PDAC.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Hoshimoto S, Hoshi N, Hishinuma S, et al. Clinical implications of the proliferative ability of the squamous component regarding tumor progression of adenosquamous carcinoma of the pancreas: A preliminary report. Pancreatology. 2017; 17(5):788-94.

    Article  PubMed  Google Scholar 

  2. Zhao X, Li H, Lyu S, et al. Single-cell transcriptomics reveals heterogeneous progression and EGFR activation in pancreatic adenosquamous carcinoma. Int J Biol Sci. 2021; 17(10):2590-605.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Boyd CA, Benarroch-Gampel J, Sheffield KM, Cooksley CD, Riall TS. 415 patients with adenosquamous carcinoma of the pancreas: a population-based analysis of prognosis and survival. J Surg Res. 2012; 174(1):12-9.

    Article  PubMed  Google Scholar 

  4. Wild AT, Dholakia AS, Fan KY, et al. Efficacy of platinum chemotherapy agents in the adjuvant setting for adenosquamous carcinoma of the pancreas. J Gastrointest Oncol. 2015; 6(2):115-25.

    PubMed  PubMed Central  Google Scholar 

  5. De Souza AL, Saif MW. Platinum-based therapy in adenosquamous pancreatic cancer: experience at two institutions. Jop. 2014; 15(2):144-6.

    PubMed  Google Scholar 

  6. Silvestris N, Brunetti O, Pinto R, et al. Immunological mutational signature in adenosquamous cancer of pancreas: an exploratory study of potentially therapeutic targets. Expert Opin Ther Targets. 2018; 22(5):453-61.

    Article  CAS  PubMed  Google Scholar 

  7. Silvestris N, Danza K, Longo V, et al. Angiogenesis in adenosquamous cancer of pancreas. Oncotarget. 2017; 8(56):95773-9.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Su W, Zhao S, Chen Y, et al. (18)F-FDG PET/CT feature of pancreatic adenosquamous carcinoma with pathological correlation. Abdom Radiol (NY). 2020; 45(3):743-9.

    Article  PubMed  Google Scholar 

  9. Matsubayashi H, Matsui T, Yabuuchi Y, et al. Endoscopic ultrasonography guided-fine needle aspiration for the diagnosis of solid pancreaticobiliary lesions: Clinical aspects to improve the diagnosis. World J Gastroenterol. 2016; 22(2):628-40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Lee YN, Moon JH, Kim HK, et al. A triple approach for diagnostic assessment of endoscopic ultrasound-guided fine needle aspiration in pancreatic solid masses and lymph nodes. Dig Dis Sci. 2014; 59(9):2286-93.

    Article  PubMed  Google Scholar 

  11. Yasuda I, Iwashita T, Doi S. Tips for endoscopic ultrasound-guided fine needle aspiration of various pancreatic lesions. J Hepatobiliary Pancreat Sci. 2014; 21(5):E29-33.

    Article  PubMed  Google Scholar 

  12. Olson MT, Siddiqui MT, Ali SZ. The differential diagnosis of squamous cells in pancreatic aspirates: from contamination to adenosquamous carcinoma. Acta Cytol. 2013; 57(2):139-46.

    Article  CAS  PubMed  Google Scholar 

  13. Ding Y, Zhou J, Sun H, et al. Contrast-enhanced multiphasic CT and MRI findings of adenosquamous carcinoma of the pancreas. Clin Imaging. 2013; 37(6):1054-60.

    Article  PubMed  Google Scholar 

  14. Toshima F, Inoue D, Yoshida K, et al. Adenosquamous carcinoma of pancreas: CT and MR imaging features in eight patients, with pathologic correlations and comparison with adenocarcinoma of pancreas. Abdom Radiol (NY). 2016; 41(3):508-20.

    Article  PubMed  Google Scholar 

  15. Imaoka H, Shimizu Y, Mizuno N, et al. Ring-enhancement pattern on contrast-enhanced CT predicts adenosquamous carcinoma of the pancreas: a matched case-control study. Pancreatology. 2014; 14(3):221-6.

    Article  PubMed  Google Scholar 

  16. Imaoka H, Shimizu Y, Mizuno N, et al. Clinical characteristics of adenosquamous carcinoma of the pancreas: a matched case-control study. Pancreas. 2014; 43(2):287-90.

    Article  CAS  PubMed  Google Scholar 

  17. Schawkat K, Tsai LL, Jaramillo-Cardoso A, et al. Use of ring-enhancement and focal necrosis to differentiate pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma on CT and MRI. Clin Imaging. 2021; 73:134-8.

    Article  PubMed  Google Scholar 

  18. Ren S, Zhao R, Cui W, et al. Computed Tomography-Based Radiomics Signature for the Preoperative Differentiation of Pancreatic Adenosquamous Carcinoma From Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020; 10:1618.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Moons KG, Altman DG, Reitsma JB, et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015; 162(1):W1-73.

    Article  PubMed  Google Scholar 

  20. Hansen TM, Nilsson M, Gram M, Frøkjær JB. Morphological and functional evaluation of chronic pancreatitis with magnetic resonance imaging. World J Gastroenterol. 2013; 19(42):7241-6.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Hester CA, Augustine MM, Choti MA, et al. Comparative outcomes of adenosquamous carcinoma of the pancreas: An analysis of the National Cancer Database. J Surg Oncol. 2018; 118(1):21-30.

    Article  PubMed  Google Scholar 

  22. Feng YF, Chen JY, Chen HY, et al. 110 Patients with adenosquamous carcinomas of the pancreas (PASC): imaging differentiation of small (≤ 3 cm) versus large (> 3 cm) tumors. Abdom Radiol (NY). 2019; 44(7):2466-73.

    Article  PubMed  Google Scholar 

  23. Iemura A, Yano H, Mizoguchi A, Kojiro M. A cholangiocellular carcinoma nude mouse strain showing histologic alteration from adenocarcinoma to squamous cell carcinoma. Cancer. 1992; 70(2):415-22.

    Article  CAS  PubMed  Google Scholar 

  24. Gao J, Han F, Jin Y, Wang X, Zhang J. A Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Pancreatic Ductal Adenocarcinoma. Front Oncol. 2020; 10:1654.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Liang Y, Schott D, Zhang Y, et al. Auto-segmentation of pancreatic tumor in multi-parametric MRI using deep convolutional neural networks. Radiother Oncol. 2020; 145:193-200.

    Article  PubMed  Google Scholar 

  26. Voong KR, Davison J, Pawlik TM, et al. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol. 2010; 41(1):113-22.

    Article  CAS  PubMed  Google Scholar 

  27. Lee L, Ito T, Jensen RT. Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies. Expert Rev Anticancer Ther. 2018; 18(9):837-60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Cantisani V, Mortele KJ, Levy A, et al. MR imaging features of solid pseudopapillary tumor of the pancreas in adult and pediatric patients. AJR Am J Roentgenol. 2003; 181(2):395-401.

    Article  PubMed  Google Scholar 

  29. Hu F, Hu Y, Wang D, et al. Cystic Neoplasms of the Pancreas: Differential Diagnosis and Radiology Correlation. Front Oncol. 2022; 12:860740.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This work was supported in part by the National Science Foundation for Scientists of China (Grant Nos. 81871352, 82171915, 82171930, U1809205, 62171230, 92159301, 62101365 and 91959207), The Natural Science Foundation of Shanghai Science and Technology Innovation Action Plan (Grant Nos. 21ZR1478500, 21Y11910300), Clinical Research Plan of SHDC (SHDC2020CR4073), and 234 Platform Discipline Consolidation Foundation Project (Grant Nos. 2019YPT001, 2020YPT001).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Jun Xu, Chengwei Shao or Yun Bian.

Ethics declarations

Conflict of interest

The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 34 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, Q., Zhou, Z., Chen, Y. et al. Fully automated magnetic resonance imaging-based radiomics analysis for differentiating pancreatic adenosquamous carcinoma from pancreatic ductal adenocarcinoma. Abdom Radiol 48, 2074–2084 (2023). https://doi.org/10.1007/s00261-023-03801-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00261-023-03801-8

Keywords

Navigation